Skip to content

Participant Database for Autism Research Studies

Database for Persons Interested in Research Studies of Developmental Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00549731
Enrollment
40
Registered
2007-10-26
Start date
2013-06-01
Completion date
2023-06-01
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Keywords

autism, autistic, language, development, developmental, assessment

Brief summary

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Detailed description

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group Aim 3: to maintain subject information in a database, from which we can recruit for our studies

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
National Institutes of Health (NIH)
CollaboratorNIH

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
14 Years to 32 Years
Healthy volunteers
Yes

Inclusion criteria

* Typically-developing, healthy adolescents and adults (ages 14-32) * Adolescents and adults with autism spectrum disorder (ages 14-32)

Exclusion criteria

* Extreme premature birth (\<34 weeks) * Known genetic disorders related to autism (e.g. Fragile X) * Recent diagnosis of psychosis (within 6 months) * Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome). * Metal implants / permanent retainers / hair dyes with metallic components

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORTal Kenet, Ph.D

Massachusetts General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026